Scientists say special immune cells in the body can damage bone marrow over the years and contribute to leukaemia, a ...

Inflammation covertly rewires the bone marrow, enabling mutated stem cells to rise and setting the stage for future blood disease.

And the discovery could soon lead to personalized treatments for children with leukemia and bone marrow failure disorders. The research, led by Murdoch Children's Research Institute (MCRI) and ...

The study shows that fat tissue, when processed and cultured in a specific way, can self-organize into structures resembling ...

The term “rare blood disorders” describes less common conditions that affect blood cells’ ability to function correctly. Myeloproliferative disorders and lymphoproliferative disorders are two types of ...

Cellenkos® Inc., a clinical-stage biotechnology company developing allogeneic, off-the-shelf, regulatory T cell (Treg) ...

PARIS (Reuters) - Sanofi has halted all clinical trials and cancelled plans to seek regulatory approval of fedratinib, a drug in late-stage development against rare bone marrow cancers, due to safety ...

A bone marrow biopsy is a medical procedure used to collect a small sample of bone marrow, which is the soft, spongy tissue inside your bones where blood cells are made. This test helps a physician ...

Myeloblasts are precursors to specific types of white blood cells that help your body fight infections. Too many myeloblasts may be a sign of a blood cancer like leukemia. Myeloblasts, or blast cells, ...

Noncancerous blood disorders are conditions that affect blood cells, such as red blood cells, white blood cells, and platelets. Blood disorders may cause symptoms and complications, but most are ...